Status:
COMPLETED
Testosterone Replacement for Male Opioid Agonist Maintained Patients
Lead Sponsor:
Yale University
Conditions:
Chronic Pain
Opioid Addiction
Eligibility:
MALE
18-50 years
Phase:
PHASE1
PHASE2
Brief Summary
This study is designed to develop an effective treatment intervention for chronic pain, symptomatic hypogonadism, and opioid addiction
Detailed Description
This study aims to assess the initial efficacy of testosterone replacement in male opioid agonist patients with symptomatic hypogonadism and chronic pain. The study has two specific aims: 1. To esti...
Eligibility Criteria
Inclusion
- Between 18 and 50 years of age
- Male buprenorphine- or methadone-maintained patients at the APT Foundation
- Moderate to severe chronic pain
- Meet criteria for symptomatic hypogonadism
- Understand English
- Interested in receiving testosterone replacement
Exclusion
- Current suicide or homicide risk
- Life-threatening or unstable medical condition
- Known or suspected prostate or chest cancer or history of polycythemia
Key Trial Info
Start Date :
April 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT01873989
Start Date
April 1 2012
End Date
January 1 2015
Last Update
June 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MRU, APT Foundation, Inc
New Haven, Connecticut, United States, 06519